Regulatory decisions diverge over aducanumab for Alzheimer’s disease
File(s)aducanuambV2 (clean).docx (97.2 KB)
Accepted version
Author(s)
Lythgoe, Mark P
Jenei, Kristina
Prasad, Vinay
Type
Journal Article
Date Issued
2022-01-28
Date Acceptance
2022-01-01
Citation
BMJ, 2022, 376, pp.1-2
ISSN
1759-2151
Publisher
BMJ
Start Page
1
End Page
2
Journal / Book Title
BMJ
Volume
376
Copyright Statement
© 2022 The Author(s). This article has been accepted for publication in [insert journal name] following peer review. The definitive copyedited, typeset version Lythgoe M P, Jenei K, Prasad V. Regulatory decisions diverge over aducanumab for Alzheimer’s disease BMJ 2022; 376 :e069780 is available online at: https://doi.org/10.1136/bmj-2021-069780
Identifier
https://www.bmj.com/content/376/bmj-2021-069780
Subjects
General & Internal Medicine
1103 Clinical Sciences
1117 Public Health and Health Services
Publication Status
Published
Date Publish Online
2022-01-28